Key result
This editorial summarizes five articles on endocrine-related cardiovascular diseases, highlighting advances in understanding lipocalin-2, alpha-adrenergic receptors, empagliflozin, caIMR, and thyroid hormone sensitivity.
No takes yet. Share an insight, caveat, or question.
Bhat et al. (2023) conducted an editorial in Endocrine-related cardiovascular diseases. This editorial summarizes five articles on endocrine-related cardiovascular diseases, highlighting advances in understanding lipocalin-2, alpha-adrenergic receptors, empagliflozin, caIMR, and thyroid hormone sensitivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: